Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?

被引：1
|
作者：
Erridge, Simon [1 ,2 ]
Sodergren, Mikael H. [1 ,2 ,3 ]
机构：
[1] Imperial Coll London, Imperial Coll Med Cannabis Res Grp, Dept Surg & Canc, London, England
[2] Sapphire Med Clin, London, England
[3] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit,Med Cannabis Res Grp, 10th Floor QEQM,South Wharf Rd, London W2 1NY, England
来源：
INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷 / 02期
关键词：
D O I：
10.1093/ibd/izad221
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [21] Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease
    Dolinsek, Jernej
    Riznik, Petra
    Sabath, Larisa
    Micetic-Turk, Dusanka
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (7-8) : 253 - 259
  • [22] Fecal calprotectin as a marker of severity of mucosal involvement in children with inflammatory bowel disease
    Dolinsek, J.
    Riznik, P.
    Sabath, L.
    Micetic-Turk, D.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S155 - S155
  • [23] The Clinical Benefit of Procalcitonin to Assess Disease Activity and Severity in Inflammatory Bowel Disease
    Nishio, Eri
    Saruta, Masayuki
    Arihiro, Seiji
    Matsuoka, Mika
    Mitsunaga, Makoto
    Ide, Daisuke
    Iwasaki, Tetsuyoshi
    Ogawa, Maiko
    Sawada, Ryoichi
    Nagata, Yusuke
    Kato, Tomohiro
    Tajiri, Hisao
    GASTROENTEROLOGY, 2016, 150 (04) : S995 - S995
  • [24] CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH ACTIVE ENDOSCOPIC INFLAMMATION
    Loeb, Lauren P.
    Picco, Michael F.
    Hashash, Jana G.
    Farraye, Francis A.
    Kinnucan, Jami A.
    GASTROENTEROLOGY, 2024, 166 (05) : S1129 - S1130
  • [25] Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
    Weiss, Alexandra
    Friedenberg, Frank
    DRUG AND ALCOHOL DEPENDENCE, 2015, 156 : 84 - 89
  • [26] Factors Associated With Cannabis Use Among Inpatients With Inflammatory Bowel Disease Exacerbation
    Oseni, Ellen
    Blumenthal, Miriam
    Qiu, Michael
    Izard, Stephanie
    Mone, Anjali
    Swaminath, Arun
    Sultan, Keith
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S666 - S667
  • [27] CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND DOCUMENTED CANNABIS USE DISORDERS: A MULTICENTER NETWORK STUDY
    Tanner, Samuel
    Perez, Jaime
    Martin, Scott A.
    Mansoor, Emad
    Katz, Jeffry
    Cominelli, Fabio
    Nguyen, Vu Q.
    GASTROENTEROLOGY, 2023, 164 (06) : S458 - S458
  • [28] The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study
    Glickman, Danny
    Dalessio, Shannon
    Raup-Konsavage, Wesley M.
    Vrana, Kent E.
    Coates, Matthew D.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (07) : 1055 - 1061
  • [29] Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis
    Pusateri, Antoinette
    Anaizi, Ahmad
    Nemer, Laura
    Hinton, Alice
    Lara, Luis
    Afzali, Anita
    CROHNS & COLITIS 360, 2022, 4 (02)
  • [30] Re: Marker of inflammatory bowel disease
    Srinivasan, R
    Colman, RW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (07): : 1849 - 1850
12345